510(k) Report

FDA applicant

Proscia, Inc.

Philadelphia, PA2 decisions2024–20260 recalls

FDA records 2 decisions for Proscia, Inc. (Philadelphia, PA) from 2024 to 2026: 2 510(k) clearances. Most are in product codes PSY (Whole Slide Imaging System) and QKQ (Digital Pathology Image Viewing And Management…). Its devices cite 3 predicates, 1 of them its own earlier devices. No recall is linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, pathology panel, where it files most

How often FDA has decided Proscia, Inc.’s devices, and how often a recall has named them.

FDA decisions per year

1in 2024

2024: 12026 (partial year): 1
2024high 1 (2024) · low 0 (2025)2026

2026 so far, outlined.

Recalls per year

No recall linked to its devices since 2024.

FIG. 1 — Proscia, Inc. by year, 2024–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Proscia, Inc.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Which product codes does it file in?

  • PSYWhole Slide Imaging System1decision
  • QKQDigital Pathology Image Viewing And Management Software1decision

Whose devices does it build on?

Its devices cite 3 predicates; 1 are its own earlier devices. The firms it cites most:

Which of its devices are cited most?

Its devices that later submissions most often claim equivalence to.

  • K230839Concentriq DxProscia, Inc. · 20241cites it

What has FDA decided for it lately?

  • K261380Concentriq AP-DxProscia, Inc. · 2026
  • K230839Concentriq DxProscia, Inc. · 2024

All 2 as Proscia, Inc. →